The scope of the PET-RANO group is the evaluation of the clinical value of PET imaging in neuro-oncology, to define response criteria for PET, and to integrate PET in both daily routine and clinical trials.
Development of PET-based response criteria for meningioma
Development of a PET-based classification for residual glioblastoma tissue after surgical resection
Evaluation of the prognostic value of amino acid PET in patients with glioblastoma in an early stage of disease
Evaluation of the added value of serial FET PET in glioblastomas to diagnose treatment-related changes

Professor for Nuclear Medicine
LMU Munich, Germany

Professor of Neurology
Head, Outpatient Neuro-Oncology Clinic
University Hospital Cologne
Copyright © 2025 Rano Group - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.